Haleon (NYSE:HLN) Sees Unusually-High Trading Volume – Here’s Why

Haleon PLC Sponsored ADR (NYSE:HLN) shares saw unusually-strong trading volume on Wednesday . Approximately 12,725,629 shares traded hands during trading, an increase of 43% from the previous session’s volume of 8,882,040 shares.The stock last traded at $10.1450 and had previously closed at $10.27.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on the company. Rothschild & Co Redburn lowered Haleon from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, June 16th. Deutsche Bank Aktiengesellschaft reissued a “sell” rating on shares of Haleon in a research note on Thursday, April 30th. Zacks Research cut shares of Haleon from a “hold” rating to a “strong sell” rating in a research report on Tuesday, July 21st. Wall Street Zen upgraded shares of Haleon from a “hold” rating to a “buy” rating in a research note on Sunday, July 12th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Haleon in a report on Tuesday, June 30th. Two equities research analysts have rated the stock with a Strong Buy rating, three have given a Buy rating, three have given a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy”.

Haleon Price Performance

The company has a market cap of $45.21 billion, a price-to-earnings ratio of 26.32, a PEG ratio of 2.30 and a beta of 0.13. The company’s 50 day moving average price is $9.40 and its 200-day moving average price is $9.85. The company has a debt-to-equity ratio of 0.47, a quick ratio of 0.71 and a current ratio of 0.92.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the business. Morgan Stanley increased its stake in Haleon by 16.0% in the 4th quarter. Morgan Stanley now owns 21,495,383 shares of the company’s stock valued at $217,318,000 after buying an additional 2,962,856 shares during the period. Norges Bank bought a new stake in shares of Haleon in the 4th quarter valued at approximately $163,529,000. Arrowstreet Capital Limited Partnership raised its position in Haleon by 82.8% during the first quarter. Arrowstreet Capital Limited Partnership now owns 14,674,518 shares of the company’s stock valued at $146,892,000 after acquiring an additional 6,647,329 shares in the last quarter. Bank of America Corp DE increased its stake in shares of Haleon by 116.7% during the 2nd quarter. Bank of America Corp DE now owns 12,384,135 shares of the company’s stock worth $128,423,000 after purchasing an additional 6,669,923 shares during the last quarter. Finally, Sculptor Capital LP raised its position in shares of Haleon by 5.1% in the fourth quarter. Sculptor Capital LP now owns 10,454,868 shares of the company’s stock valued at $105,699,000 after purchasing an additional 505,000 shares during the period. 6.67% of the stock is owned by institutional investors and hedge funds.

About Haleon

Haleon plc (NYSE:HLN) is a global consumer healthcare company formed through the separation of a large pharmaceutical group’s consumer health business in 2022. Headquartered in the United Kingdom, Haleon develops, manufactures and markets a broad portfolio of over‑the‑counter medicines, oral health products, vitamins, minerals and supplements, and other consumer health goods designed for daily self‑care and symptom relief.

The company’s product mix spans categories such as oral care (toothpastes and sensitivity treatments), pain relief and analgesics, respiratory remedies, digestive health products, topical treatments and nutritional supplements.